These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 15552864)
41. Rizatriptan induced acute on top of chronic ischemic colitis. Alkhatib AA; Gangotena F; Peterson KA Am J Gastroenterol; 2009 Oct; 104(10):2643-4. PubMed ID: 19806107 [No Abstract] [Full Text] [Related]
42. Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness? Millson D; Frischer M; Croft P; Goadsby PJ Cephalalgia; 2000 Oct; 20(8):732-7. PubMed ID: 11167903 [TBL] [Abstract][Full Text] [Related]
43. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy. Goadsby PJ; Yates R Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161 [TBL] [Abstract][Full Text] [Related]
44. Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain--results of a model-based meta-analysis that accounts for encapsulation. Mandema JW; Cox E; Alderman J Cephalalgia; 2005 Sep; 25(9):715-25. PubMed ID: 16109054 [TBL] [Abstract][Full Text] [Related]
54. Almotriptan (Axert) and frovatriptan (Frova) for migrane. Med Lett Drugs Ther; 2002 Feb; 44(1124):19-20. PubMed ID: 11856954 [No Abstract] [Full Text] [Related]
55. Unilateral time-delayed encapsulation does not make for a fair race. Loftus BD Headache; 2003 Sep; 43(8):921; author reply 924-8. PubMed ID: 12940818 [No Abstract] [Full Text] [Related]
56. [Probabilistic cost-effectiveness analysis of oral eletriptan in the treatment of acute migraine in Portugal]. Félix JM; Inês MS; Acosta CM Acta Med Port; 2005; 18(1):77-87. PubMed ID: 16202337 [TBL] [Abstract][Full Text] [Related]
57. Safety profile of almotriptan, a new antimigraine agent. Effects on central nervous system, renal function and respiratory dynamics. Gras J; Llupià J; Llenas J; Palacios JM Arzneimittelforschung; 2001 Sep; 51(9):726-32. PubMed ID: 11642004 [TBL] [Abstract][Full Text] [Related]
58. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg. Diener HC Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900 [TBL] [Abstract][Full Text] [Related]
59. [Bonus-malus regulations in the framework of the AVWG guideline-suitable migraine therapy are possible]. MMW Fortschr Med; 2007 May; 149 Suppl 2():102-3. PubMed ID: 17724980 [No Abstract] [Full Text] [Related]
60. [New meta-analysis of triptanes. Concrete help, so the choice doesn't become overwhelming]. MMW Fortschr Med; 2002 May; Suppl 2():58. PubMed ID: 12070852 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]